MedPath

NOVANTRONE INJ 2MG/ML

NOVANTRONE INJ 2MG/ML

Discontinued
DIN Number

00614289

Drug Class

Human

Market Date

Dec 31, 1984

Company
HC

lederle cyanamid canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00614289
AIG Number0116465001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01DB07 MITOXANTRONE
Product Specifications
Dosage FormLiquid
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE)Active
Strength: 2 MG / ML
Monograph: MITOXANTRONE (MITOXANTRONE HYDROCHLORIDE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.